FY

Fu Yuning

Chairman of the Board

China Resources Pharmaceutical Group

China Resources Pharmaceutical Group Pipeline

DrugIndicationPhase
Chemical Generics PortfolioVarious (Cardiovascular, CNS, Anti-infective)Approved
Traditional Chinese Medicine PortfolioVarious Chronic Diseases & WellnessApproved
Biosimilar CandidatesOncology, Autoimmune DiseasesPhase 3
Innovative Drug R&D ProgramsOncology, Metabolic DiseasesPhase 1/2